Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study.
Valenza C, Nicolò E, Mongillo M, Trapani D, Katrini J, Boldrini L, Boscolo Bielo L, Castellano G, Guidi L, Pellizzari G, Villa J, Derio S, Lapresa M, Gigli F, Parma G, Omodeo Salè E, Derenzini E, Curigliano G, Colombo N. Valenza C, et al. Among authors: trapani d. Oncologist. 2024 Nov 28:oyae330. doi: 10.1093/oncolo/oyae330. Online ahead of print. Oncologist. 2024. PMID: 39607864 Free article.
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study.
Valenza C, Trapani D, Zagami P, Antonarelli G, Boscolo Bielo L, Nicolò E, Ribeiro JM, Guidi L, Reduzzi C, Spotti M, Adamoli L, Cortès J, Pistilli B, Tolaney SM, Ueno N, Layman RM, Cristofanilli M, Carey LA, Munzone E, Criscitiello C, Lynce F, Woodward WA, Curigliano G. Valenza C, et al. Among authors: trapani d. Eur J Cancer. 2024 Dec;213:115097. doi: 10.1016/j.ejca.2024.115097. Epub 2024 Oct 28. Eur J Cancer. 2024. PMID: 39486164
Molecular tumor board in patients with metastatic breast cancer.
Boscolo Bielo L, Guerini Rocco E, Crimini E, Repetto M, Lombardi M, Zanzottera C, Aurilio G, Barberis M, Belli C, Zhan Y, Battaiotto E, Katrini J, Marsicano R, Zagami P, Taurelli Salimbeni B, Esposito A, Trapani D, Criscitiello C, Fusco N, Marra A, Curigliano G. Boscolo Bielo L, et al. Among authors: trapani d. Breast Cancer Res Treat. 2024 Oct 30. doi: 10.1007/s10549-024-07535-z. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39476312
Developing combination therapies with biologics in triple-negative breast cancer.
Gaudio G, Martino E, Pellizzari G, Cavallone M, Castellano G, Omar A, Katselashvili L, Trapani D, Curigliano G. Gaudio G, et al. Among authors: trapani d. Expert Opin Biol Ther. 2024 Oct;24(10):1075-1094. doi: 10.1080/14712598.2024.2408756. Epub 2024 Oct 3. Expert Opin Biol Ther. 2024. PMID: 39360776 Review.
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations.
Boscolo Bielo L, Guerini Rocco E, Trapani D, Zagami P, Taurelli Salimbeni B, Esposito A, Belli C, Crimini E, Venetis K, Munzone E, Fusco N, Criscitiello C, Marra A, Curigliano G. Boscolo Bielo L, et al. Among authors: trapani d. ESMO Open. 2024 Oct;9(10):103731. doi: 10.1016/j.esmoop.2024.103731. Epub 2024 Oct 1. ESMO Open. 2024. PMID: 39357123 Free PMC article.
282 results